SCHEMBL29777419

SCHEMBL29777419

CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O

nearest known ligand 0.48

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ENPEP Q07075 17/20 0.48
▸ GNPAT O15228 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30092240 0.93 ENPEP (0.49) ENPEPGNPAT
SCHEMBL31206444 0.93 ENPEP (0.47) ENPEPGNPAT
SCHEMBL29625209 0.90 ENPEP (0.48) ENPEPGNPAT
SCHEMBL30182696 0.89 VIPR2 (0.47) ENPEP
SCHEMBL30239619 0.89 NPY4R (0.43) ENPEP
SCHEMBL29995282 0.89 NPY4R (0.45) —
SCHEMBL31277463 0.88 ENPEP (0.46) ENPEP
SCHEMBL30303032 0.88 ENPEP (0.46) ENPEP
SCHEMBL30085019 0.88 NPY4R (0.43) —
SCHEMBL31318675 0.88 ENPEP (0.47) ENPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4591934-A2 VARIANTS OF C-TYPE NATRIURETIC PEPTIDE BioMarin Pharmaceutical Inc. (US) 2025-07-30 — — EP disclosed
EP-4523749-A2 VARIANTS OF C-TYPE NATRIURETIC PEPTIDE BioMarin Pharmaceutical Inc. (US) 2025-03-19 — — EP disclosed
EP-4029512-A1 VARIANTS OF C-TYPE NATRIURETIC PEPTIDE BioMarin Pharmaceutical Inc. (US) 2022-07-20 — — EP disclosed
Send feedback